Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Much Is the Global Calcitonin Injection Market Valued at Present and by 2029?

The market for calcitonin injections has witnessed significant expansion in the past few years. The market value is expected to increase from $0.67 billion in 2024 to $0.73 billion in 2025, at a Compound Annual Growth Rate (CAGR) of 8.5%. The growth during the historic period can be associated with factors such as the growing incidences of osteoporosis, enhanced awareness about bone health, growth of postmenopausal treatment alternatives, the availability of government-sponsored health care subsidies and an increase in the elderly population.

In the coming years, the calcitonin injection market is poised for robust growth, with its size estimated to reach $0.99 billion by 2029 at an 8.2% compound annual growth rate (CAGR). Factors driving this projected growth include an increasing need for treatments, a surge in biosimilar competition, growing requirements in emerging economies, a shift towards personalized healthcare, and expanded research into other uses for calcitonin. The forecasted period is likely to see trends like the growth in intranasal and injectable delivery methods, enhanced formulations with longer half-lives, the creation of biosimilar calcitonin products, innovation in osteoporosis management strategies, and advancements in diagnostic tools.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24490&type=smp

#What Drivers Are Influencing Growth In The Calcitonin Injection Market?

The rise in osteoporosis cases is anticipated to promote the expansion of the calcitonin injection market. Osteoporosis, a clinical situation characterized by reduced bone density and an elevated risk of fractures, predominantly impacts the elderly, specifically postmenopausal women. The uptick in osteoporosis instances can be attributed to ageing, with longer life spans leading to inherent bone density deterioration and an increased likelihood of the condition. Calcitonin injections aid in the management of osteoporosis by controlling calcium levels and decelerating bone loss, proving to be effective in preserving bone density. These injections offer a focused treatment approach, enhancing patient adherence and lowering fracture risks. As an example, data from the Australian Institute of Health and Welfare in June 2024 indicates that 853,600 individuals (3.4%) in Australia lived with osteoporosis or osteopenia in 2022, contributing to 2,659 deaths, or 1.4% of all deaths. As such, this rise in osteoporosis prevalence is bolstering the growth of the calcitonin injection market.

What Are The Main Segments Identified In The Calcitonin Injection Market Research?

The calcitonin injection market covered in this report is segmented –

1) By Type Of Calcitonin: Salmon Calcitonin, Human Calcitonin, Synthetic Calcitonin

2) By Route Of Administration: Intravenous (IV) Injection, Subcutaneous Injection, Intramuscular Injection

3) By Distribution Channel: Direct Sales, Online Pharmacy, Retail Pharmacy, Healthcare Institutions

4) By Therapeutic Application: Osteoporosis Treatment, Pagets Disease Management, Hypercalcemia Control, Bone Metastases Therapy

5) By End-User: Hospitals, Specialty Clinics, Geriatric Care Facilities, Home Healthcare

Subsegments:

1) By Salmon Calcitonin, Synthetic Salmon Calcitonin, Recombinant Salmon Calcitonin

2) By Human Calcitonin, Recombinant Human Calcitonin, Synthetic Human Calcitonin

3) By Synthetic Calcitonin, Peptide-Based Synthetic Calcitonin, Analog Synthetic Calcitonin

What Are The Leading Trends And Opportunities In The Calcitonin Injection Sector?

Leading firms in the calcitonin injection market are emphasizing on the development of groundbreaking products like USP synthetic injections. This strategy aims to increase the effectiveness of treatments and yield better results for patients. A USP synthetic injection is a type of medication that is injected and is composed of artificially created active compounds that adhere to the strict rules of purity, quality, strength, and consistency laid down by the United States Pharmacopeia (USP). They are produced in a controlled environment to ensure their safety and efficacy for therapeutic usage. For example, Fresenius Kabi, a pharmaceutical corporation based in Germany, introduced a USP synthetic calcitonin salmon injection in February 2025. This is meant for the treating symptomatic Paget’s disease of the bone and hypercalcemia. The prepared sterile solution is fit for intramuscular or subcutaneous injection, and is available in 200 USP units per mL, packaged in a multi-dose 2 mL vial containing 400 USP units. This medication, which regulates calcium, needs to be stored in refrigerated conditions, between 2°C and 8°C. It is indicated for the management of symptomatic Paget’s disease of bone in cases where alternative therapies are inappropriate, as well as hypercalcemia, and postmenopausal osteoporosis when no other suitable options are available.

Which Companies Play A Key Role In The Development Of The Calcitonin Injection Market?

Major companies operating in the calcitonin injection market are Kaiser Permanente, F. Hoffmann-La Roche AG, Sanofi S.A., Novartis AG, AstraZeneca plc, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Viatris Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Limited, Dr. Reddy’s Laboratories Limited, Cipla Limited, Hikma Pharmaceuticals plc, Endo International plc, Asahi Kasei Pharma Corporation, Torrent Pharmaceuticals Limited, BCN Peptides S.L., SG Pharmaceuticals Pvt Ltd, Leucadia Pharmaceuticals Inc., Polypeptide Group AB

Get The Full Report Here:

https://www.thebusinessresearchcompany.com/report/calcitonin-injection-global-market-report

What Are The Key Regional Developments Shaping The Calcitonin Injection Market?

North America was the largest region in the calcitonin injection market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the calcitonin injection market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=24490&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model